Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for BRKR
20.37
-0.19 (-0.92%)
Jul 2 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 20.18 - 20.61
52 week 17.26 - 24.72
Open 20.61
Vol / Avg. 299,823.00/988,175.00
Mkt cap 3.44B
P/E 63.37
Div/yield     -
EPS 0.32
Shares 168.87M
Beta 1.09
Inst. own 70%
Sep 8, 2015
Bruker Corp at Morgan Stanley Healthcare Conference Add to calendar
Aug 5, 2015
Q2 2015 Bruker Corp Earnings Call - 4:45PM EDT - Add to calendar
Aug 5, 2015
Q2 2015 Bruker Corp Earnings Release - 4:00PM EDT - Add to calendar
Jun 17, 2015
Bruker Corp at Wells Fargo Healthcare Conference
Jun 9, 2015
Bruker Corp at William Blair Annual Growth Stock Conference
Jun 9, 2015
Bruker Corp at Goldman Sachs Healthcare Conference
Jun 2, 2015
Bruker Corp at Jefferies Global Healthcare Conference
May 20, 2015
Bruker Corp Annual Shareholders Meeting
May 18, 2015
Bruker Corp at UBS Global Healthcare Conference
May 12, 2015
Bruker Corp at Bank of America Merrill Lynch Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 1.95% 3.29%
Operating margin 4.30% 5.83%
EBITD margin - 10.76%
Return on average assets 1.52% 3.09%
Return on average equity 3.52% 7.03%
Employees 6,100 -
CDP Score - -

Address

40 MANNING RD
BILLERICA, MA 01821
United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group and the Bruker Nano Group. BEST designs, manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America, and it has sales offices located throughout the world.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Anthony L. Mattacchione Interim Chief Financial Officer, Senior Vice President - Finance & Accounting
Age: 51
Bio & Compensation  - Reuters
Thomas W. Bachmann President of Bruker BioSpin Group
Age: 56
Bio & Compensation  - Reuters
Bernd Gewiese Ph.D. Co-President of Bruker BioSpin Corporation
Age: 55
Bio & Compensation  - Reuters
Werner E. Maas Ph.D. Co-President of Bruker BioSpin Corporation
Age: 49
Bio & Compensation  - Reuters
Mark R. Munch Ph.D. President, Bruker Nano Surfaces Division and Bruker MAT Group
Age: 53
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group
Age: 60
Bio & Compensation  - Reuters
Michael Gunnar Knell Vice President - Finance, Chief Accounting Officer
Age: 38
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 67
Bio & Compensation  - Reuters
Joerg C. Laukien Director
Age: 61
Bio & Compensation  - Reuters